Status:
COMPLETED
Breath Analysis to Diagnose Lung Cancer
Lead Sponsor:
University Hospital, Lille
Collaborating Sponsors:
Institut National de Recherche en Informatique et en Automatique
Institut Pasteur de Lille
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Determination of volatile organic compounds to discriminate patients with lung cancer from healthy smokers and non-smokers healthy subjects.
Eligibility Criteria
Inclusion
- patients with histologically proven lung cancer
- Controls:
- healthy smoker or non-smoker subjects
- without respiratory diseases excepted chronic obstructive pulmonary disease.
Exclusion
- history of cancer other than lung cancer within 5 years before inclusion
- oral or facial malformation
- incomprehension of maneuvers for the collection
Key Trial Info
Start Date :
April 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 29 2024
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT03250390
Start Date
April 29 2019
End Date
April 29 2024
Last Update
April 15 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Pasteur - Centre de Prévention et d'Education à la Santé (CPES)
Lille, France, 59000
2
Hôpital Calmette, CHU
Lille, France
3
Hopital Victor Provo
Roubaix, France
4
Centre Hospitalier de Saint Quentin
Saint-Quentin, France